8 results match your criteria: "Hematology Collaborative Innovation Center[Affiliation]"
Zhonghua Xue Ye Xue Za Zhi
June 2022
The First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, National Center for Hematology and Clinical Research, Hematopoietic Stem Cell Transplantation Institute of Soochow University, Hematology Collaborative Innovation Center, Suzhou 215006, China.
To study hematopoietic stem cell transplantation-related bleeding prognosis and construct a bleeding prediction model. The clinical data of 555 patients with malignant hematologic diseases who underwent allogeneic hematopoietic stem cell transplantation between May 1(st) 2004, and April 1(st) 2012 was analyzed retrospectively, and a prediction model was constructed. Of the 555 patients, a total of 302 (54.
View Article and Find Full Text PDFFuture Med Chem
March 2022
Jiangsu Key Laboratory of Neuropsychiatric Diseases & College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, 215123, PR China.
Necroptosis is an important form of regulated cell death involved in inflammatory diseases, degenerative diseases and cancer. RIPK3 is an interesting target for intervention of necroptosis-associated diseases. Herein the authors report the synthesis of a series RIPK3 inhibitors under the guidance of structure-based drug design which leads to the identification of compound .
View Article and Find Full Text PDFZhonghua Xue Ye Xue Za Zhi
December 2021
Peking University People' s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China Hematology Collaborative Innovation Center, Peking University, Beijing 100044, China.
Zhonghua Nei Ke Za Zhi
October 2020
Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation,National Clinical Research Center for Hematologic Disease, Beijing 100044, China; Hematology Collaborative Innovation Center, Suzhou 215006, China.
To analyze the immunophenotype and cytogenetic characteristics of primary plasma cell leukemia (pPCL), and to evaluate the efficacy of bortezomib and hematopoietic stem cell transplantation as main treatment. A retrospective cohort study was conducted including 42 pPCL patients admitted to Peking University People's Hospital from January 1998 to March 2019. All patients were followed up until December 31, 2019.
View Article and Find Full Text PDFZhonghua Xue Ye Xue Za Zhi
July 2020
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China; Hematology Collaborative Innovation Center, Peking University, Beijing 100871, China.
To retrospectively analyze the impact of primary PGF on CMV pneumonia in patients who have undergone haplo-HSCT. The clinical data of 122 patients who underwent haplo-HSCT at the Peking University Institute of Hematology from 2011-2012 were retrospectively reviewed. The incidence rate of CMV pneumonia between PGF and good graft function (GGF) was compared, and the factors were analyzed.
View Article and Find Full Text PDFZhonghua Xue Ye Xue Za Zhi
April 2020
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
To retrospectively analyzed the impact of splenomegaly on outcomes in patients with chronic myelomonocytic leukemia (CMML) receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) . Clinical data of 25 patients with CMML receiving allo-HSCT at Peking University Institute of Hematology from 2004-2018 were retrospectively analyzed. Engraftment, graft versus host disease (GVHD) , relapse, survival were compared between patients with or without splenomegaly before transplantation.
View Article and Find Full Text PDFZhonghua Xue Ye Xue Za Zhi
February 2017
First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Hematology Collaborative Innovation Center, Suzhou 215006, China.
To explore the practical value of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma (MM) patients. The clinical data of 107 newly diagnosed MM patients at hematology department of the first affiliated hospital of Soochow's University from September 2012 to January 2016 were retrospectively analyzed. The results of all the 60 patients who were performed WB-DWI before treatment were analyzed.
View Article and Find Full Text PDFZhonghua Xue Ye Xue Za Zhi
May 2016
First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of thrombosis and hemostasis of Ministry of health , Hematology Collaborative Innovation Center, Suzhou 215006, China.
Objective: The roles of serum free light chain ratio (sFLCR) in the diagnosis and prognosis of newly diagnosed multiple myeloma (NDMM) patients were analyzed.
Methods: The clinical data was retrospectively analyzed for 82 newly diagnosed multiple myeloma (NDMM) patients in the first affiliated hospital of Soochow University from September 28, 2012 to July 18, 2105. The serum free light chain levels were measured and κ/λ ratios were calculated, so we could analyze the roles of sFLCR in the diagnosis and prognosis of newly diagnosed multiple myeloma (NDMM) patients.